BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mousavi T, Nikfar S, Abdollahi M. An update on efficacy and safety considerations for the latest drugs used to treat irritable bowel syndrome. Expert Opin Drug Metab Toxicol 2020;16:583-604. [PMID: 32380874 DOI: 10.1080/17425255.2020.1767067] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Mousavi T, Nikfar S, Abdollahi M. An update on the use of pharmacotherapy for opioid-induced bowel dysfunction. Expert Opin Pharmacother 2022;:1-17. [PMID: 36548911 DOI: 10.1080/14656566.2022.2161883] [Reference Citation Analysis]
2 Meng YY, Wang EK, Wang YS, Feng Y, Hang L, Yuan JY. Progress in traditional Chinese medicine study of constipation predominant irritable bowel syndrome. Shijie Huaren Xiaohua Zazhi 2022; 30(20): 892-896 [DOI: 10.11569/wcjd.v30.i20.892] [Reference Citation Analysis]
3 Lu Q, Tan D, Luo J, Ye Y, Zuo M, Wang S, Li C. Potential of natural products in the treatment of irritable bowel syndrome. Phytomedicine 2022. [DOI: 10.1016/j.phymed.2022.154419] [Reference Citation Analysis]
4 Mousavi T, Nikfar S, Abdollahi M. The pharmacotherapeutic management of duodenal and gastric ulcers. Expert Opin Pharmacother 2021;:1-27. [PMID: 34435515 DOI: 10.1080/14656566.2021.1959914] [Reference Citation Analysis]
5 Gros M, Gros B, Mesonero JE, Latorre E. Neurotransmitter Dysfunction in Irritable Bowel Syndrome: Emerging Approaches for Management. J Clin Med 2021;10:3429. [PMID: 34362210 DOI: 10.3390/jcm10153429] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 7.0] [Reference Citation Analysis]
6 Mousavi T, Nikfar S, Abdollahi M. Comprehensive study on the administrative, economic, regional, and regulatory prospects of complementary and alternative medicine (CAM) in inflammatory bowel disease (IBD). Expert Rev Clin Pharmacol 2021;14:865-88. [PMID: 33993811 DOI: 10.1080/17512433.2021.1925108] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Schiattarella A, Riemma G, Sisti G, Savoia F, Rapisarda A, De Franciscis P, Morlando M. Efficacy of phloroglucinol in shortening the first stage of labor: systematic review and meta-analysis of randomized controlled trials. J Matern Fetal Neonatal Med 2021;:1-7. [PMID: 34102932 DOI: 10.1080/14767058.2021.1936488] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Cil O, Haggie PM, Tan JT, Rivera AA, Verkman AS. SLC26A6-selective inhibitor identified in a small-molecule screen blocks fluid absorption in small intestine. JCI Insight 2021;6:147699. [PMID: 34100381 DOI: 10.1172/jci.insight.147699] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
9 Bruta K, Vanshika, Bhasin K, Bhawana. The role of serotonin and diet in the prevalence of irritable bowel syndrome: a systematic review. transl med commun 2021;6. [DOI: 10.1186/s41231-020-00081-y] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
10 Daniali M, Nikfar S, Abdollahi M. Antibiotic resistance propagation through probiotics. Expert Opin Drug Metab Toxicol 2020;16:1207-15. [PMID: 32938241 DOI: 10.1080/17425255.2020.1825682] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]